England’s NICE To Help Colombia Boost Access To Medicines
Move Is Part Of NICE’s Aim To Build ‘Mutually-Beneficial’ Relations Across Region
Executive Summary
The agreement should help Colombia improve its HTA process and access to medicines there.
You may also be interested in...
Everyone Wants A Piece Of The UK's NICE
Heath technology assessment body NICE says it has relaunched its international division to deal with the growing number of enquiries for advice it has been receiving from government agencies and organizations abroad.
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.
New HTA Evidence Guidelines In EU Could Spell Trouble For Advanced Therapy Companies
New guidelines that cast doubt over use of single-arm and non-randomized studies are “discouraging” for rare disease patients and the advanced therapy sector, says ARM, the Alliance for Regenerative Medicines.